Page 4 - Heart Failure Guidelines
P. 4

Pediatric Heart Failure Guidelines

               Table of Contents

               Preface ...................................................................................................................................... 3
               Heart Failure - General Considerations ...................................................................................... 6
                  Heart Failure - Initial Evaluation .............................................................................................. 6
                  Heart Failure Disease Staging for Infants & Children .............................................................. 6
                  Heart Failure Symptom Severity Classification ....................................................................... 7
                  Heart Failure Medications ....................................................................................................... 8
                  Heart Failure Anticoagulation ................................................................................................11
                  Heart Failure Nutrition ...........................................................................................................11
                  Heart Failure Exercise ...........................................................................................................12
                  Heart Failure Advanced Therapies ........................................................................................13
                  Heart Failure Follow-up Schedule ..........................................................................................14
               Dilated Cardiomyopathy (DCM) ................................................................................................15

                  Additional Evaluation for DCM ...............................................................................................15
                  Medical Management DCM ...................................................................................................15
                  Follow-up Schedule for DCM .................................................................................................15
               Hypertrophic Cardiomyopathy (HCM) .......................................................................................16

                  Additional Diagnostic Evaluation for HCM .............................................................................16
                  Management HCM ................................................................................................................16
                  Follow-up Schedule for Hypertrophic Cardiomyopathy ..........................................................18
               Restrictive Cardiomyopathy (RCM) ...........................................................................................19

                  Additional Evaluation for RCM ...............................................................................................19
                  Medical Management RCM ...................................................................................................19
                  Follow-up Schedule for Restrictive Cardiomyopathy ..............................................................19
               Non-Compaction Cardiomyopathy (LVNC) ................................................................................21

                  Additional Evaluation for LVCN .............................................................................................21
                  Medical Management for LVCN .............................................................................................21
                  Follow-up Schedule for LVCN ...............................................................................................21

               Congenital Heart Disease with Heart Failure .............................................................................22
                  Additional Evaluation for CHD with Heart Failure ...................................................................22
                  Management and Long-Term Follow-up for CHD with Heart Failure ......................................22
               Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) ......................................................23
                  Additional Evaluation for ARVC .............................................................................................23
                  Medical Management for ARVC ............................................................................................23
                  Follow up for ARVC ...............................................................................................................23
               Chemotherapy Induced Cardiomyopathy ..................................................................................24
                  Additional Evaluation for Patient with Chemotherapy Induced Cardiomyopathy ....................24
                  Medical Management Chemotherapy Induced Cardiomyopathy ............................................24
                  Follow-up Schedule for Chemotherapy Induced Cardiomyopathy ..........................................24




               Updated 5/17/2018                                                                       page 4
   1   2   3   4   5   6   7   8   9